Home › NDC Lookup › RxCUI directory › RxCUI 1251190

Lactulose 10000 MG Powder for Oral Solution — RxCUI 1251190

RxNorm drug concept · Semantic clinical drug
RxCUI 1251190 Semantic clinical drug · SCD ● Current RxNorm concept 8 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1251190
Official nameLactulose 10000 MG Powder for Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aslactulose 10 GM Powder for Oral Solution; lactulose 10 GM Granules for Oral Solution
FDA products mapped8
Package NDCs mapped8
Reported Medicaid activity (SDUD)28,988 prescriptions · 18 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Lactulose: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Lactulose has two main uses. Some products — like Constulose and Kristalose — are prescribed specifically for constipation. Other products, like Enulose and Generlac, are used for...
  • For constipation, it usually takes 24 to 48 hours to produce a bowel movement, so don't be worried if nothing happens right away. For portal-systemic encephalopathy, improvement ma...
  • How long does it take lactulose to work?
  • The most common side effects are digestive — gas, bloating, belching, and mild stomach cramping. These are pretty typical, especially when you first start. The one to watch for is...
📖 Read our full Lactulose guide →

🕸️ Concept Web — How Lactulose 10000 MG Powder for Oral Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Lactulose 10000 MG Powder for Oral Solution RxCUI 1251190

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Lactulose 6218
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Kristalose 217928
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Lactulose Powder for Oral Solution 1868570
    • Lactulose Oral Powder Product 1868569
    • Lactulose Oral Product 1162201
    • Lactulose Powder for Oral Solution [Kristalose] 1868573
    • Kristalose Oral Powder Product 1868574
    • Kristalose Oral Product 1174250
    • Powder for Oral Solution 1540455
    • Oral Powder Product 1294711
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Lactulose 10000 MG SCDC · 1868576
  • Lactulose Powder for Oral Solution SCDF · 1868570
  • Lactulose Oral Powder Product SCDG · 1868569
  • Lactulose Oral Product SCDG · 1162201

Brand-Name Concepts

  • Lactulose 10000 MG Powder for Oral Solution [Kristalose] SBD · 1251192
  • Lactulose 10000 MG [Kristalose] SBDC · 1868578
  • Lactulose Powder for Oral Solution [Kristalose] SBDF · 1868573
  • Kristalose Oral Powder Product SBDG · 1868574
  • Kristalose Oral Product SBDG · 1174250
  • Kristalose BN · 217928

📦 FDA Products & Package NDCs

8 products · 8 package NDCs
8 package NDCs map to RxCUI 1251190 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
66220-0719-30 30 POUCH in 1 CARTON (66220-719-30) / 10 g in 1 POUCH (6622... KRISTALOSE Cumberland Pharmaceuticals Inc. 2012-01-20
66220-0729-30 30 POUCH in 1 CARTON (66220-729-30) / 20 g in 1 POUCH (6622... KRISTALOSE Cumberland Pharmaceuticals Inc. 2012-01-20
69067-0010-15 15 POUCH in 1 CARTON (69067-010-15) / 10 g in 1 POUCH Lactulose Foxland Pharmaceuticals, Inc. 2018-09-21
69067-0020-15 15 PACKET in 1 CARTON (69067-020-15) / 20 g in 1 PACKET Lactulose Foxland Pharmaceuticals, Inc. 2025-02-07
73352-0900-15 15 POUCH in 1 CARTON (73352-900-15) / 10 g in 1 POUCH (7335... Lactulose Trifluent Pharma, Inc. 2025-09-13
73352-0905-15 15 POUCH in 1 CARTON (73352-905-15) / 20 g in 1 POUCH (7335... Lactulose Trifluent Pharma, Inc. 2025-09-13
85592-0819-30 30 POUCH in 1 CARTON (85592-819-30) / 10 g in 1 POUCH (8559... LACTULOSE Crystalline Cumberland Assured Products Inc. 2025-09-01
85592-0829-30 30 POUCH in 1 CARTON (85592-829-30) / 20 g in 1 POUCH (8559... LACTULOSE Crystalline Cumberland Assured Products Inc. 2025-09-01
Observed labelers: Cumberland Assured Products Inc. (2) · Cumberland Pharmaceuticals Inc. (2) · Foxland Pharmaceuticals, Inc. (2) · Trifluent Pharma, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.